Newsletter

Biotech NSTDA successfully developed a nasal spray COVID-19 vaccine Preparing for the first phase of human trials Use Delta species late 64

9 Aug. 21 – Ministry of Higher Education, Science, Research and Innovation The National Science and Technology Development Agency (NSTDA) by the National Center for Genetic Engineering and Biotechnology (Biotech) has developed a vaccine against the novel coronavirus disease SARS-CoV-2 or COVID-19. Nasal Spray Types: Adenovirus-based and Influenza-based which has passed the immunostimulation test in […]